Skip to main content
. Author manuscript; available in PMC: 2011 Jul 13.
Published in final edited form as: Clin Cancer Res. 2008 Jun 15;14(12):4016–4024. doi: 10.1158/1078-0432.CCR-08-0106

Table 3.

Main characteristics and PDE11A sequence changes in the AIMAH (n = 29) and controls (n = 96).

AIMAH (n = 29) Control group (n = 96) OR* (95% CI) P
Sex (F/M) 24/5 75/21
Age, y (mean ± SD) 48.7 ± 9.2 47.1 ± 0.7
c.147A>C/p.L49L (exon 3)
 A/A 28 (96) 96 (100)
 A/C 1 (4) 0 (0)
 C/C 0 (0) 0 (0)
c.354G>A/p.Q118Q(exon 3)
 G/G 29 (100) 96 (100)
 G/A 0 (0) 0 (0)
 A/A 0 (0) 0 (0)
c.480G>A/p.L160L (exon3)
 G/G 29 (100) 96 (100)
 G/A 0 (0) 0 (0)
 A/A 0 (0) 0 (0)
c.690C>T/p.C230C (exon 3)
 C/C 28 (96) 96 (100)
 C/T 1 (4) 0 (0)
 T/T 0 (0) 0 (0)
c.1072-3C>T (intron 4)
 C/C 20 (69) 79 (82) (c) (d) 2.01 (0.67–5.9) 0.23
 C/T 9 (31) 17 (18)
 T/T 0 (0) 0 (0)
c.1263A>G/p.E421E (exon 6)
 A/A 18 (62) 78 (81) (c) 1.94 (0.73–5.13) 0.19
 A/G 11 (34) 17 (18) (d) 2.25 (0.78–6.5) 0.14
 G/G 0 (0) 1 (1)
c.1577-3C/T (intron 10)
c.1626A>G/p.A542A(exon 11)
c.1644+26insGTTTATA(intron 11)
 C/C 14 (48) 42 (44) (c) 0.91 (0.47–1.7) 0.89
 C/T 11 (38) 39 (40) (d) 0.86 (0.33–2.22) 0.91
 T/T 4 (14) 15 (16) (r) 0.9 (0.2–3.36) 1
c.2758_2760insTCC/p.S920ins (exon 23)
 A/A 3 (11) 11 (11) (c) 0.72 (0.34–1.50) 0.44
 A/B 16 (55) 41 (43) (d) 0.91 (0.2–5.67) 1
 B/B 10 (34) 44 (46) (r) 0.56 (0.18–1.58) 0.34
Presence of missense/nonsense mutations Total n of mutations (%)
 Yes 7 (24) 9 (9) 3.53 0.05
 No 22 (76) 87 (91)

Frequency of different synonymous variations (polymorphisms) and missense/nonsense mutations in 29 AIMAH and sex- and age- matched controls. Values are numbers (percentages) unless otherwise stated.

*

OR (95% CI) are given for recessive (r), codominant (c), and dominant (d) models, wherever possible.